Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Adeshwar Meditex Ltd (543309)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543309 NSE: Pharmaceuticals & Drugs | Small Cap | Adeshwar Meditex Share Price
₹16.89 0.00 (0.00%)
As on 22-Sep'26 16:59
Adeshwar Meditex Ltd (543309)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543309 NSE: Pharmaceuticals & Drugs | Small Cap | Adeshwar Meditex Share Price
₹16.89 0.00 (0.00%)
As on 22-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹24 Cr.
Current Price
₹16.9
52-Week Low / High
₹13 / 22
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.9
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
4.83%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
57.68%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹14.4 Cr.
Face Value
₹10
All Time Low / High
₹13.00 / 42.00
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Adeshwar Meditex Ltd a good quality company?
Adeshwar Meditex Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Adeshwar Meditex Ltd performance compare with that of its Peers?
Revenue growth of Adeshwar Meditex Ltd vs industry peers?
Adeshwar Meditex Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Adeshwar Meditex Ltd?
Promoters hold 57.68% of the Adeshwar Meditex Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Adeshwar Meditex Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of -9.93% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Adeshwar Meditex Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'15 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 16.8% | 0% | 28.8% | 17.6% | 14.3% | 11.1% | 7% | 10.1% | 9.6% | 8.5% | - |
| Value Creation Index ⓘ | 0.2 | NA | 1.1 | 0.3 | 0.0 | -0.2 | -0.5 | -0.3 | -0.3 | -0.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 25.2 | 0 | 58.6 | 52.9 | 56.1 | 66 | 64.8 | 82.4 | 79.9 | 83.7 | 56 |
| Sales YoY Gr. | - | -100% | NA | -9.7% | 6.1% | 17.6% | -1.8% | 27.2% | -3.1% | 4.8% | - |
| Adj EPS ⓘ | 1.5 | 0 | 2.6 | 2.2 | 2 | 1.5 | 0.5 | 1.4 | 1.4 | 1.4 | 0.9 |
| YoY Gr. | - | -100% | NA | -15.2% | -9.6% | -22.8% | -65.1% | 164.2% | 0% | 1.4% | - |
| BVPS (₹) ⓘ | 8.9 | 0 | 13.6 | 15.9 | 35.9 | 19.5 | 21.5 | 22.8 | 24.2 | 25.6 | 25.6 |
| Adj Net Profit ⓘ | 1 | 0 | 2.6 | 2.2 | 2.1 | 1.6 | 0.8 | 2 | 2 | 2.1 | 1 |
| Cash Flow from Ops. ⓘ | 0 | 0 | -1.2 | -5.9 | -1 | 3.2 | -2.4 | 5.8 | 3.8 | 3.8 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | -9.9 | -3.4 | -21.5 | 7.1 | -7.8 | 2.9 | 3.6 | 3.3 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 14.3% | 8.3% | 8.9% | 4.8% | ||||
| Adj EPS ⓘ | -0.8% | -6.3% | 38.9% | 1.4% | ||||
| BVPSⓘ | 12.5% | -6.5% | 6.1% | 5.9% | ||||
| Share Price | - | -10.3% | -9.1% | -2.1% | ||||
Key Financial Parameters ⓘ
| Mar'15 | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 17.9 | 0 | 26.3 | 14.8 | 12 | 8.1 | 3 | 6.3 | 6 | 5.7 | 3.4 |
| Op. Profit Mgn % ⓘ | 7.5 | 0 | 9.4 | 7.3 | 9.8 | 7.1 | 5.2 | 6.3 | 6.5 | 5.3 | NAN |
| Net Profit Mgn % ⓘ | 4.1 | 0 | 4.4 | 4.1 | 3.7 | 2.4 | 1.2 | 2.5 | 2.5 | 2.4 | 2.3 |
| Debt to Equity ⓘ | 0.9 | 0 | 0.9 | 1.3 | 1.1 | 1.1 | 0.6 | 0.5 | 0.4 | 0.3 | - |
| Working Cap Days ⓘ | 182 | 0 | 131 | 238 | 294 | 303 | 356 | 285 | 275 | 273 | 0 |
| Cash Conv. Cycle ⓘ | 83 | 0 | 77 | 155 | 174 | 186 | 200 | 153 | 163 | 162 | 0 |
Valuation of Adeshwar Meditex - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Adeshwar Meditex Ltd FAQs
The current trading price of Adeshwar Meditex on 22-Sep-2026 16:59 is ₹16.89.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Sep-2026 the market cap of Adeshwar Meditex stood at ₹24.37 Cr
The latest P/E ratio of Adeshwar Meditex as of 21-Sep-2026 is 19.25.
The latest P/B ratio of Adeshwar Meditex as of 21-Sep-2026 is 0.66.
The 52-week high of Adeshwar Meditex is ₹21.80 and the 52-week low is ₹13.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adeshwar Meditex is ₹56.10 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Adeshwar Meditex Ltd is a below average quality company.
The key valuation ratios of Adeshwar Meditex Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Adeshwar Meditex Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Adeshwar Meditex Ltd
Adeshwar Meditex is an Indian company, engaged in the manufacturing of surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, tulle dressing, medical disposable, adhesive bandages, absorbent gauze, plaster, disinfectants, medical kits etc. The company is an ISO 13485:2016 certified Company. It has manufacturing facility situated at Deewan Industrial Estate, Palghar District. Its state-of-the-art manufacturing plant follows WHO-GMP, CE, ISO guidelines and it is backed by an advanced production facility, which is fitted with latest machinery and well organized and arranged sterilization facilities.
It endeavors to maintain safety in its premises by adhering to key safety norms. Its manufacturing facility also has sophisticated facilities for quality testing, research & development, storage and packaging. It has an in-house R&D facility for on-site process improvement and for bettering its present products offered as well as products under innovation and testing laboratory which ensures that its products are certified and any major defects in the products are identified on real time basis and rectified before the final dispatch. It has dedicated teams actively involved in R&D and QC/ QA Lab activities. These functions have impeccably streamlined and thus assure swift production and post-production processes and enable it to support its growth strategy by developing new products and processes which enhance its product range. The focus of its R&D has been to strive for continuous process improvements which will cater to the requirements of global patients from the point of view of effectiveness and safety besides achieving manufacturing cost efficiencies.
Business area of the company
The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables.
Major events in the history:
- 1997: Started business as prop. Concern Adeshwar Meditex.
- 2007: Incorporation of the Company and subsequently takeover of Proprietorship firm of our promoter Siddharth Talati, Adeshwar Meditex.
- 2015: The company Crossed turnover of Rs 25 crore.
- 2018: The company Crossed turnover of Rs 50 crore.
- 2021: Conversion of Company from “Private Limited” to “Public Limited”.
You have 48 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
